Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center.
Rita GomesSara M F S MoscaMariana Bastos-GomesLiane Maria Correia Rodrigues da Costa Nogueira SilvaLiliana RochaAna TeixeiraTeresa Maria Tavares Vieira da Costa TavaresMaria do Sameiro Pinto César de FariaPaula MatosMaria da Conceição Oliveira Costa MotaPublished in: Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (2022)
Our results confirm the efficacy and safety of RTX use in pediatric idiopathic NS and highlight its' potential cardiometabolic benefits.